(MedPage Today) — Patients with advanced gastric cancer lived about three months longer when trastuzumab (Herceptin) was added to conventional chemotherapy, investigators in a multinational trial reported.
No Comments »
Filed under: General Health News
(MedPage Today) — BETHESDA, Md. — A federal advisory panel voted 20-2 that the FDA should not grant approval for an expanded indication for sodium oxybate (Xyrem) — also known as GHB — to treat fibromyalgia. A number of panelists felt the potential for widespread abuse of the “date rape” drug was too great [...]
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Patients taking the Parkinson’s drug combo carbidopa/levodopa and entacapone (Stalevo) may be at a higher risk for cardiovascular events such as myocardial infarction, stroke, and death, the FDA said in a prepared statement.
No Comments »
Filed under: General Health News
BETHESDA, Md. (MedPage Today) — A joint FDA advisory committee will meet here Friday to consider whether the narcolepsy drug sodium oxybate (Xyrem) should receive an additional indication to treat fibromyalgia.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Patients taking the Parkinson’s drug combo carbidopa/levodopa and entacapone (Stalevo) may be at a higher risk for cardiovascular events such as myocardial infarction, stroke, and death, the FDA said in a prepared statement.
No Comments »
Filed under: Pharmacy News
Protalex, Inc., a clinical stage biopharmaceutical company engaged in developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, today announced the dosing of the first patient in a multicenter Phase 1b clinical study of PRTX-100 in adult patients with active Rheumatoid Arthritis (RA). The study is being conducted in South Africa.
No Comments »
Filed under: Pharmacy News
A Pittsburgh start-up company that received an early investment from one of Pennsylvania’s most dynamic resources has entered into an exclusive licensing agreement to help find the cure for Lou Gehrig’s disease, or ALS, Department of Community and Economic Development Secretary Austin Burke announced today.
No Comments »
Filed under: Pharmacy News
Using the innovative technique of radioembolisation to treat patients with inoperable colorectal cancer liver metastases who have failed all standard-of-care chemotherapy options can more than double the time until their disease progresses, according to the final results of a Phase III randomised controlled trial published in the prestigious Journal of Clinical Oncology.
No Comments »
Filed under: Pharmacy News
SRI International, an independent nonprofit research and development organization, announced today that it has assumed responsibility for further clinical development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd., a leading Japanese pharmaceutical company. Further clinical development will focus on the lead compound’s registration for the treatment of tamoxifen and aromatase [...]
No Comments »
Filed under: Pharmacy News
Silence Therapeutics plc, a leading international RNAi therapeutics company, is pleased to note that its partner, Quark Pharmaceuticals, Inc., has announced the grant of an option to Novartis to obtain an exclusive worldwide license to develop and commercialise QPI-1002, a p53 temporary inhibitor siRNA drug which incorporates Silence’s AtuRNAi technology.
No Comments »
Filed under: Pharmacy News
